<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Therapy on Longetivities</title><link>https://longetivities.com/tags/therapy/</link><description>Recent content in Therapy on Longetivities</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 16 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://longetivities.com/tags/therapy/feed.xml" rel="self" type="application/rss+xml"/><item><title>NAD Precursors Guide: NR, NMN, Niacin, IV Therapy, And Dosing</title><link>https://longetivities.com/blog/nad-precursors-guide-nr-nmn-niacin-iv-therapy-and-dosing/</link><pubDate>Wed, 08 Apr 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/nad-precursors-guide-nr-nmn-niacin-iv-therapy-and-dosing/</guid><description>&lt;p&gt;This nad precursors guide provides a structured, evidence-based overview of NAD+ boosting strategies through various precursors. Rather than marketing hype, you’ll find biochemical pathways, clinical evidence, dosing protocols, safety profiles, and practical applications to support informed decision-making.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Target readers include:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Clinicians seeking protocols for patient management&lt;/li&gt;
&lt;li&gt;Researchers requiring synthesized trial data and research gaps&lt;/li&gt;
&lt;li&gt;Informed consumers navigating supplements intelligently&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Key takeaways upfront:&lt;/strong&gt; Nicotinamide riboside and nicotinamide mononucleotide demonstrate the strongest human evidence for elevating NAD levels with high tolerability up to 1,200 mg/day. Nicotinic acid offers historical efficacy but carries flushing risks. Oral routes suffice for most applications, though iv therapy suits acute needs. Long-term safety data remains limited, necessitating monitoring and caution with high doses that may inhibit sirtuins.&lt;/p&gt;</description></item><item><title>Stem Cell Therapy Longevity and Regenerative Health</title><link>https://longetivities.com/blog/stem-cell-therapy-longevity-and-regenerative-health/</link><pubDate>Thu, 26 Mar 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/stem-cell-therapy-longevity-and-regenerative-health/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Emerging and Fringe Protocols&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/emerging-longevity-protocols-practical-outline-for-research-and-practice/"&gt;Emerging Longevity Protocols: Practical Outline for Research and Practice&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;In March 2026, stem cell therapy has moved from theoretical promise to clinical validation. A Phase 2b trial published in Cell Stem Cell demonstrated that older adults treated with mesenchymal stem cells walked 63.4 meters farther than placebo groups and nearly one-third transitioned from frail to non-frail status within nine months. Regenerative medicine has developed from early tissue repair concepts to advanced stem cell therapies, reflecting decades of scientific progress and innovation.&lt;/p&gt;</description></item><item><title>NAD IV Therapy Vs Supplements: Cost, Benefits, And When To Choose Each</title><link>https://longetivities.com/blog/nad-iv-therapy-vs-supplements-cost-benefits-and-when-to-choose-each/</link><pubDate>Sat, 07 Mar 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/nad-iv-therapy-vs-supplements-cost-benefits-and-when-to-choose-each/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Head-to-Head Protocol Comparisons&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/compare-longevity-protocols-practical-framework-for-low-risk-biohacking/"&gt;Compare Longevity Protocols: Practical Framework For Low-Risk Biohacking&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Nicotinamide adenine dinucleotide has become a focal point in longevity science, and choosing between NAD IV therapy and oral supplements can feel overwhelming. This guide breaks down the costs, benefits, and practical considerations so you can decide which approach fits your wellness goals.&lt;/p&gt;
&lt;p&gt;Whether you’re looking to boost energy levels, improve mental clarity, or explore anti aging options, understanding the differences between these two delivery methods is essential for making an informed choice.&lt;/p&gt;</description></item><item><title>BPC-157 Longevity Guide: Peptide Therapy, Recovery, and Risks</title><link>https://longetivities.com/blog/bpc-157-longevity-guide-peptide-therapy-recovery-and-risks/</link><pubDate>Sat, 21 Feb 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/bpc-157-longevity-guide-peptide-therapy-recovery-and-risks/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Emerging and Fringe Protocols&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/emerging-longevity-protocols-practical-outline-for-research-and-practice/"&gt;Emerging Longevity Protocols: Practical Outline for Research and Practice&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;BPC-157 has gained attention among biohackers, athletes, and longevity enthusiasts as a promising peptide therapy for accelerating tissue repair. As with any emerging therapy, it is crucial to rely on medical science—rigorous research and regulatory oversight are essential to ensure safety and effectiveness when evaluating peptide therapies like BPC-157. This comprehensive review targets those exploring regenerative medicine options—whether you’re an athlete recovering from overuse injuries or a clinician evaluating experimental recovery protocols.&lt;/p&gt;</description></item></channel></rss>